Class 2 infants - Clinically and genetically determined SMA: symptomatic or paucisymptomatic infants with homozygous deletion of SMN1 exon 7 or compound heterozygotes with the c.840C > T conversion, and a variable number of SMN2 copies. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.